Table 2.
Associations between HLA class II and leprosy.
Population | Study design | Sample size | Phenotype | Serotype, allele, or haplotype | Type of association | P or Pc | Ref. |
---|---|---|---|---|---|---|---|
Japanese | Case-control | 295LL, 74TL, 110 controls | LL/TT LL |
DR2 DRw9 |
Susceptibility Resistance |
Pc < 0.008 Pc < 0.0001 |
[12] |
| |||||||
Thai | Case-control | 32TT, 32 controls | TT | DR2 DQw1 |
Susceptibility Susceptibility |
Pc = 0.02 Pc = 0.008 |
[22] |
| |||||||
Korean | 157LD, 162 controls | LD | DR1 DR2 DR9 DR4 DRw53 DQw1 DQw3 |
Susceptibility Susceptibility Susceptibility Resistance Resistance Susceptibility Resistance |
P = 0.02 P < 0.0001 P = 0.02 P < 0.0001 P < 0.0001 P < 0.0001 P < 0.0001 |
[13] | |
| |||||||
Turkish | Case-control | 23LL, 27BL, 50 controls | LL/BL | DR2 | Susceptibility | P = 0.015 | [23] |
| |||||||
Asian Indian | Case-control | 23TT, 16PTB, 19 controls | TT | DRB1*15:02 | Susceptibility | P < 0.05 | [24] |
| |||||||
Indian | Case-control | 138LD, 237 controls | LD | DR2 DQw1 DQw7 |
Susceptibility Susceptibility Susceptibility |
Pc = 0.00031 Pc = 0.0004 Pc = 0.00031 |
[15] |
Case-control | 68LL, 237 controls | LL | DR2 DQw1 |
Susceptibility Susceptibility |
Pc = 0.0063 Pc = 0.02 |
||
Case-control | 30BL, 237 controls | BL | DR9 DQw7 |
Susceptibility Susceptibility |
Pc = 0.04 Pc = 0.0006 |
||
| |||||||
Indian | Case-control | 28TT, 65LL, 47 controls | LL |
DRB1*15
DRB1*15:01 DRB1*07:01 DRB5*01:01 DQB1*06:01 DQA1*01:02 DQA1*01:03 DQA1*02:01 |
Susceptibility Susceptibility Susceptibility Susceptibility Susceptibility Susceptibility Susceptibility Susceptibility |
P < 0.0001 P < 0.001 P < 0.01 P < 0.001 P < 0.0001 P < 0.01 P < 0.01 P < 0.01 |
[25] |
Case-control | 28TT, 65LL, 47 controls | TT |
DRB1*15
DRB1*15:02 DQB1*0601 DQB1*05:03 |
Susceptibility Susceptibility Susceptibility Resistance |
P < 0.01 P < 0.05 P < 0.01 P < 0.01 |
||
| |||||||
Indian | Case-control | 39TT, 20PTB, 46 controls | TT |
DRB1*15:02
Haplotype: DRB1*1501-DRB5*0101-DQA1*0102-DQB1*0502 |
Susceptibility Resistance |
P < 0.05 P < 0.05 |
[26] |
| |||||||
Indian | Case-control | 54TT, 44 controls | TT | DRB1*15 | Susceptibility | Pc = 0.0063 | [27] |
| |||||||
Japanese | Case-control | 38LL/BL, 79LD, 50 controls | BL/LL LD |
DRB1*02
DRB1*12 |
Susceptibility Resistance |
P = 0.037 P = 0.013 |
[28] |
| |||||||
Brazilian | Case-control | 32TT, 147 controls | TT | DR2 | Susceptibility | Pc = 0.0132 | [29] |
| |||||||
Japanese | Case-control | 93LD, 114 controls | LD |
DRB1*04:05
DQA1*03 DQB1*04:01 |
Resistance Resistance Resistance |
Pc < 0.05 Pc < 0.05 Pc < 0.05 |
[30] |
| |||||||
Brazilian | TDT | 73 families (147 sib-pairs) | LD |
DQB1*02:01
DQB1*05:01 DRB1*7 |
Resistance Susceptibility Resistance |
Pc = 0.008 Pc = 0.008 Pc = 0.036 |
[31] |
TDT | 73 families (147 sib-pairs) | TT |
DQB1*02:01
DQB1*05:01 |
Resistance Susceptibility |
Pc = 0.024 Pc = 0.024 |
||
| |||||||
Egyptian | Case-control | 24LD, 30 controls | LD | DR2 DQ1 |
Susceptibility Susceptibility |
P = 0.032 P = 0.015 |
[32] |
| |||||||
Southern Indian | TDT | 223 ASP | TT |
DRB1*15(2)
DRB1*09 |
Susceptibility Resistance |
P = 0.012 P = 0.004 |
[33] |
| |||||||
Argentinean | Case-control | 70LL, 112 controls | LL |
DQB1*02:01
DQB1*02:02 DQB1*02:03 |
Resistance | Pc = 0.02 | [34] |
Case-control | 19PB, 112 controls | TT | DRB1*04 | Resistance | Pc = 0.0192 | ||
| |||||||
North Indian | Case-control | 34BT/TT, 79BL/LL, 111 controls | BL/LL | DRB1*15:01 | Susceptibility | P < 0.05 | [35] |
| |||||||
Brazilian | Case-control | 578LD, 691 controls | LD |
DRB1*04
DRB1*07 DRB1*10 DRB1*12 DRB1*15 |
Resistance Resistance Susceptibility Resistance Susceptibility |
Pc = 0.04076 Pc = 0.04753 Pc = 0.02102 Pc = 0.04399 Pc = 0.02288 |
[36] |
Euro-Brazilian | Case-control | 578LD, 691 controls | LD |
DRB1*04/NNc
DRB1*07/NNc |
Resistance Resistance |
Pc = 0.01 Pc = 0.01 |
|
Afro-Brazilian | Case-control | 578LD, 691 controls | LD |
DRB1*10/NNc
DRB1*15/NNc |
Susceptibility Susceptibility |
Pc = 0.024 Pc = 0.0002 |
|
Vietnam | TDT | 194 single-case families | LD |
DRB1*10
DRB1*04 |
Susceptibility Resistance |
Pc = 0.04 Pc = 0.03 |
|
| |||||||
Argentinean | Case-control | 71LD, 81 controls | LD |
DRB1*14:01
DRB1*14:06 DRB1*08:08 DRB1*11:03 |
Susceptibility Susceptibility Resistance Resistance |
Pc = 0.0011 Pc = 0.0011 Pc = 0.0006 Pc = 0.0004 |
[37] |
| |||||||
Chinese | Case-control | 305LD, 527 controls | LD |
DRB1*15
DRB1*09 |
Susceptibility Resistance |
Pc = 0.002 Pc = <0.001 |
[38] |
| |||||||
Brazilian | Case-control | 30BL, 178 controls | BL | DRB1*16:01 | Susceptibility | Pc = 0.0208 | [39] |
Case-control | 63LL, 43TT | LL | DRB1*08 | Susceptibility | Pc = 0.0481 | ||
| |||||||
Taiwanese | Case-control | 65LD 190 controls | ML | DRB1*04:05 | Resistance | Pc = <0.0001 | [40] |
| |||||||
Brazilian | Case-control | 17LL, 77 control | LL | DRB1*11 | Resistance | Pc = 0.0132 | [41] |
| |||||||
Brazilian | Case-control | 36LL, 85 control | LL | DRB1*16 | Susceptibility | Pc = 0.0105 | [42] |
Case-control | 20TT, 85 control | TT | DRB1*14 | Susceptibility | Pc = 0.032 |
MB: multibacillary leprosy; PB: paucibacillary; LL: lepromatous leprosy; BL: borderline lepromatous; BB: borderline borderline; TT: tuberculoid leprosy; PTB: pulmonary tuberculosis; LD: leprosy disease; NNc: all not significantly different alleles collapsed into a unique group (i.e., DRB1*04, 07, 10, 12, and 15) [36]; ASP: affected sib-pair; ns: not significant; Pc: corrected P value; Ref.: reference.